CoordenaÃÃo de AperfeiÃoamento de NÃvel Superior / Introduction: Visceral leishmaniasis is a serious public health problem in several parts of the developing world. In leishmaniasis, protection and healing correlate with the development of Th1 immune response, and IFN-γ is considered a key molecule in this response. In contrast, the Th2 response results in disease progression. It is noteworthy that after contact with Leishmania the production of IFN-γ differs between healthy individuals. Some of them are high IFN-γ producer (HIFN-γP), while others respond with low IFN-γ producer (LIFN-γP). This has been observed in the in vitro response to several species of Leishmania, as well as in the early phase of the disease in patients with leishmaniasis. The activation of T lymphocytes can be modulated by immunomodulatory receptors present on the surface of lymphocytes and antigen presenting cells (APCs). Signaling lymphocytic activation molecule (SLAM, CD150) is a transmembrane protein that promotes Th2 differentiation. Evidences support the involvement of this molecule in the immune response against parasites. Objective: To evaluate the role of SLAM signaling pathway in the modulation of immune response of peripheral blood mononuclear cells (PBMC) from individuals low IFN-γ producers (LP) against Leishmania chagasi. Methodology: Healthy individualsâ PBMC were stimulated in vitro with L. chagasi and monoclonal anti-SLAM (α-SLAM), in the presence or not of inflammatory cytokines (rIFN-γ or rIL-12). The supernatants of the cultures were analyzed by ELISA for the determination of IFN-γ and interleukin 10 (IL-10) concentrations. Results: Upon stimulation of PBMC with L. chagasi, the blocking of the SLAM signaling pathway with α-SLAM did not affect the synthesis of IFN-γ and IL-10, regardless of treatment with rIL-12. However, after rIFN-γ treatment of antigen stimulated cells it occurred a download of IL-10 synthesis and upload IFN-γ secretion, regardless of the blockade of SLAM signaling pathway. Conclusions: The blocking of SLAM signaling pathway with α-SLAM at the concentration of 10μg/mL does not interfere significantly in the IFN-γ and IL-10 production of PBMC from individuals LP stimulated with Leishmania chagasi promastigotes. Treatment of PBMC with rIFN-γ is able to induce a reduction of IL-10 and an increment of IFN-γ in the supernates cultures, whereas treatment with rIL-12 enhanced IFN-γ production, but does not interfered with IL-10. It is necessary to make further studies to better understand the role of the SLAM signaling pathway in the immune response of LP against Leishmania chagasi. / IntroduÃÃo: Nas leishmanioses, proteÃÃo e cura se correlacionam com o desenvolvimento de resposta imune tipo Th1, e IFN-γ à considerada uma molÃcula chave nesta resposta. Ao contrÃrio, a resposta Th2, resulta na progressÃo da doenÃa. Vale ressaltar que a produÃÃo de IFN-γ, apÃs o contato com a Leishmania, difere entre indivÃduos sadios, alguns apresentam alta produÃÃo de IFN-γ (AP), enquanto outros respondem com baixa produÃÃo (BP). Isto tem sido observado com diversas espÃcies de Leishmania, assim como na infecÃÃo natural, na fase inicial da doenÃa. A ativaÃÃo do linfÃcito T pode ser modulada por coestimuladores, presentes na superfÃcie de linfÃcitos e nas APCs, a exemplo da molÃcula sinalizadora na ativaÃÃo de linfÃcitos T (SLAM). EvidÃncias apontam para o envolvimento dessas molÃculas na regulaÃÃo da resposta imunolÃgica. Objetivo: Avaliar o papel da via de sinalizaÃÃo de SLAM na modulaÃÃo da resposta imune em cÃlulas mononucleares de sangue perifÃrico (CMSP) de indivÃduos BP, frente à estimulaÃÃo in vitro por Leishmania chagasi. Metodologia: CMSP de indivÃduos sadios BP foram estimuladas in vitro com L. chagasi na ausÃncia ou na presenÃa do anticorpo monoclonal anti-SLAM (α-SLAM), com ou sem tratamento por citocinas proinflamatÃrias (rIFN-γ ou rIL-12). Os sobrenadantes das culturas foram analisados por ELISA para IFN-γ e interleucina (IL)-10. Resultados: Sob estimulaÃÃo de L. chagasi, o bloqueio da via SLAM nÃo modificou a sÃntese de IFN-γ e IL-10, independente do tratamento com rIL-12. No entanto, o tratamento com rIFN-γ reduziu a sÃntese de IL-10 e elevou a secreÃÃo de IFN-γ endÃgeno, independente do bloqueio da via SLAM. ConclusÃes: O bloqueio da via SLAM, com adiÃÃo de α-SLAM (10Âg/mL), nÃo interfere significativamente na produÃÃo de IFN-γ e IL-10. O tratamento das CMSP com rIFN-γ à capaz de induzir a reduÃÃo da produÃÃo de IL-10 e o aumento de IFN-γ de forma significativa, enquanto que o tratamento com rIL-12 aumenta a produÃÃo de IFN-γ, mas nÃo interfere na produÃÃo de IL-10 dos indivÃduos baixos produtores. Faz-se necessÃrio ampliar o estudo da aÃÃo imunomoduladora da SLAM frente à Leishmania chagasi, para um melhor entendimento do papel desta via de sinalizaÃÃo na resposta imunolÃgica dos BP.

Visceral leishmaniasis (VL) causes fatal life-threatening disease, if left untreated. The current drugs have various limitations; hence, natural products from medicinal plants are being focused in search of new drugs to treat leishmaniasis. The aim of the present study was to evaluate the antileishmanial and immunomodulatory activities of F5 and F6 alcoholic fractions from Withania somnifera leaves and purified withaferin-A in Leishmania donovani-infected peritoneal macrophages and BALB/c mice. We observed that F5 (15 mu g/mL), F6 (10 mu g/mL), and withaferin-A (1.5 mu M) reduce amastigote count in peritoneal macrophages and induce reactive oxygen species and significant decrease in IL-10 mRNA expression compared to control upon treatment. Subsequently, in vivo study mice were treated with F5 (25 and 50 mg/kg b.wt.), F6 (25 and 50 mg/kg b.wt.) orally, and withaferin-A (2 mg/kg b.wt.) intraperitoneally for 10 consecutive days and a drastic reduction in parasite burden in both spleen and liver were observed. The treatment resulted in the reduction in IL-10, IL-4, and TGF-beta mRNA expression and a significant increase in IFN-gamma /IL-10 expression ratio in the treated group compared to control. The humoral response of these alcoholic fractions and withaferin-A shows increased IgG2a levels when compared with IgG1 in treated mice. Taken together, our result concludes that withanolides in alcoholic fractions demonstrate a potent antileishmanial and immunomodulatory activities in experimental VL.

Natural Killer (NK) cells, lymphocytes of the innate immune response, play a vital role in controlling infections and in tumor surveillance. NK cells provide protection by direct cytolysis of infected cells and by the production of pro-inflammatory cytokines such as, IFN-γ and TNF-α. Notably, NK cells have recently been identified to regulate the immune response by producing the anti-inflammatory cytokine IL-10. Several other cells can produce IL-10 during infections, however NK cell derived IL-10 can be critical in regulating immune response during early phases of infection and therefore protecting the host from excessive immunopathology. Although the regulatory role of NK cells seems to be plausible, the physiological relevance of NK cell mediated immune regulation during infections has not been demonstrated in detail. To investigate the immunoregulatory function of NK cells, I used Murine Cytomegalovirus (MCMV) infection induced by a high dose challenge and demonstrated that NK cells are a major IL-10 producer during acute stage of the infection. To elucidate the role of NK cell derived IL-10 during infections, I generated NK cell specific IL-10 knockout, NKp46iCre  Il-10flox/flox mice (NK-Il-10-/-) by crossing Il-10flox/flox mice with mice expressing Cre recombinase exclusively under the NK cell specific promoter, NKp46 (NKp46iCre knock-in mice). My results indicated that Cre mediated Il-10 genomic deletion occurred predominantly in NK cells but not in NKT, T and B cells. Enriched NK cells from NK-Il-10-/- mice failed to produce IL-10 upon ex vivo IL-2/IL-12 stimulation. Furthermore, histological analysis of the colon indicated that NK-Il-10-/- mice are free from aberrant inflammation. During sustained MCMV infection, significantly higher production of IFN-γ by CD8+ T cells of NK-Il-10-/- mice in salivary glands indicates that NK cell derived IL-10 contributes to the establishment of the immune suppressive environment in the organ. NK-Il-10-/- mice also demonstrated increased susceptibility to acute Listeria monocytogenes (LM) infection based on enhanced body weight loss. Taken together, I have successfully generated NK-Il-10-/- mice that lack the Il-10 gene exclusively in NK cells. The NK-Il-10-/- mouse can be used as an ideal model to dissect the immunoregulatory role of NK cells during various microbial infections and tumorogenesis.

Indiana University-Purdue University Indianapolis (IUPUI) / The immune system provides resistance to the myriad of pathogens in the environment, but can also respond inappropriately causing allergic inflammation and autoimmune disease. CD4+ T cells, which play a crucial role in adaptive immune system, can be divided into several subsets based on their effector functions. T helper 9 (Th9) cells, derived by the IL-4/STAT6 and TGF-β signaling pathways, produce IL-9 as a hallmark cytokine, as well as IL-10. Through IL-9 production, Th9 cells protect against parasite infection but are also involved in allergic inflammation and autoimmune diseases. Transcription factors that promote Th9 development include STATs, PU.1, BATF, and IRF4. In this study, we identify ETV5 as a factor that promotes IL-9 and IL-10 production by binding to cis-acting regulatory elements in the respective genes. At the Il9 gene, ETV5 cooperates with PU.1 in regulating gene expression. At the Il10 gene, ETV5 facilitates binding of other transcription factors to the locus. These studies and others suggested that there may be additional cis-acting regulatory elements in the Il9 gene. We demonstrate that a conserved noncoding sequence (CNS) located 25 kb upstream of the Il9 transcription start site, termed Il9 CNS-25, is critical for regulating Il9 expression in Th cell subsets. Th9 cells derived from Il9 CNS-25 mutant (Il9 ΔCNS-25) mice produce significantly less IL-9. Il9 CNS-25 promoted chromatin modifications at the promoter and accessibility of the locus. Il9 ΔCNS-25 mice showed attenuated airway inflammation compared to control mice. The Il9 CNS-25 region in mice is conserved with an IL9 CNS-18 region in the human genome. We deleted CNS-18 in primary human Th9 cells and observed diminished IL-9 production. Thus, we have identified transcription factors that regulate multiple cytokines in Th cell lineages and have demonstrated that the Il9 CNS-25/IL9 CNS-18 elements are respectively critical for Il9/IL9 gene expression.

Indiana University-Purdue University Indianapolis (IUPUI) / The adaptive arm of the immune system is necessary for facial motoneuron (FMN) survival after facial nerve axotomy (FNA). CD4+ T cells mediate FMN survival after FNA in an interleukin-10 (IL-10) dependent manner, but are not themselves the cellular source of neuroprotective IL-10. The aims of this study are to elucidate the neuroprotective capacity of cell-specific IL-10 expression, and to investigate the manner in which CD4+ T cells participate in IL-10 signaling after FNA. Immunohistochemistry revealed that FMN themselves were constitutive producers of IL-10, and astrocytes were induced to make IL-10 after FNA. Il10 mRNA co-localized with microglia before and after axotomy, but microglial production of IL-10 protein was not detected. To determine whether any single source of IL-10 is critical for FMN survival, Cre/Lox mouse strains were utilized to selectively knock out IL-10 in neurons, astrocytes, and microglia. In agreement with the localization data reflecting concerted IL-10 production by multiple cell types, no single cellular source of IL-10 was necessary for FMN survival. Gene expression analysis of wild-type, immunodeficient, and immune cell-reconstituted animals was performed to determine the role of the immune system in modulating the central IL-10 signaling cascade. This revealed that CD4+ T cells were necessary for full upregulation of central IL-10 receptor (IL-10R) expression after FNA, regardless of their own IL-10R beta (IL-10RB) expression or IL-10R signaling capability. Surprisingly, the ability of CD4+ T cells to respond to IL-10 was critical for their ability to mediate neuroprotection. Adoptive transfer of IL-10RB-deficient T cells resulted in increased central expression of genes associated with microglial activation, antigen presentation, T cell co-stimulation, and complement deposition in response to injury. These data suggest that IL-10RB functions on the T cell to prevent non-neuroprotective immune activation after axotomy. The conclusions drawn from this study support a revised hypothesis for the mechanisms of IL-10-mediated neuroprotection, in which IL-10 serves both trophic and immune-modulating roles after axotomy. This research has implications for the development of immune-modifying therapies for peripheral nerve injury and motoneuron diseases. / 2 years (2021-05-24)

Systemic Lupus Erythematosus (SLE) stands as a multifaceted autoimmune disorder, characterized by a spectrum of clinical manifestations and the generation of autoantibodies against self-antigens. Our focus was on the pivotal role of B cells in the development of SLE. The study also underscored the significant contribution of regulatory B (Breg) cells in the context of SLE, suggesting their potential as key regulators of the disease process. Our results provided a deeper understanding of the intricate interplay between B cells and SLE, offering insights that were valuable for both scientific research and future designs of therapeutic approaches. Cutting-edge single-cell RNA sequencing was employed to analyze the differences in splenic Breg subsets and their molecular profiles across different stages of lupus development in mice. Transcriptome-based changes in Bregs during active disease were confirmed through phenotypic analysis. These findings provided crucial insights into the dynamic role of B cells in the pathogenesis of SLE. In addition, we delved into the intricate connection between SLE and the gut microbiota. A literature review offered a comprehensive analysis of current research, with a particular emphasis on potential interactions between bacterial flagellin and Toll-Like Receptor 5 (TLR5) on immune cells. These interactions garnered substantial attention due to their potential implications in the pathogenesis of SLE. We synthesized existing research, providing valuable insights into the complex interplay between SLE and the microbiota and suggesting promising avenues for further investigation and potential therapeutic interventions. In the final study, we explored lupus-like disease in mice with global Tlr5 deletion, initially expecting disease attenuation. Surprisingly, the results revealed an exacerbation of lupus-like symptoms, particularly in female mice lacking Tlr5. Future research will seek to uncover the mechanisms by which Tlr5 deletion modulates interactions between the host and the gut microbiota, ultimately contributing to the exacerbation of lupus-like disease. / Doctor of Philosophy / Systemic Lupus Erythematosus (SLE) is characterized by a range of health issues and the body attacking itself. In this exploration, we journey through the intricate landscape of SLE, uncovering key players and unexpected twists. In this dissertation, we journeyed through the intricate landscape of SLE, uncovering key players and unexpected twists. In this dissertation, we closely examined these immune cells, revealing how different types of B cells contributed to SLE's development. We also introduced the enigmatic regulatory B (Breg) cells, which acted as potential peacekeepers in this autoimmune reaction. Our results illuminated the complex relationship between B cells and SLE, offering insights that benefited both researchers and those seeking new treatments. We employed cutting-edge technology, single-cell RNA sequencing, to scrutinize the genetic fingerprints of B cells in mice with SLE. The results unveiled changes in Breg cells during active disease, providing critical clues about how B cells impacted SLE progression. In addition, this dissertation took us into the microscopic world of our gut inhabitants, the microbiota. We dived into a treasure trove of research, focusing on how interactions between bacterial flagellin and various microbiota elements affected immune cells through a special receptor called Toll-Like Receptor 5 (TLR5). These interactions, like hidden clues, had piqued scientists' interest for their potential role in SLE development. We synthesized existing research, offering valuable insights into the complex interplay between SLE and our microbiota. The discussion also suggested promising paths for future research and potential therapies. In the final study, we encountered a plot twist. We anticipated that deleting the Tlr5 gene would improve lupus-like disease in mice. To our surprise, the opposite happened. Lupus-like symptoms worsened, especially in female mice lacking Tlr5. Clinical signs included enlarged spleens and lymph nodes, increased immune cell activity, and kidney inflammation. But Tlr5 deletion didn't change the mice's metabolism or the leaky gut. Instead, it reshaped their gut's microbial residents. Future research aimed to uncover how Tlr5 deletion altered the interactions between the host and gut microbes, ultimately making lupus-like disease more severe. In a nutshell, this journey through SLE's complex world provided a deeper understanding of its intricacies. We met the B cells, explored the microbiota, and encountered surprises along the way. These discoveries were vital pieces of the puzzle, bringing us closer to unlocking the secrets of SLE and, perhaps, finding new ways to manage and treat this challenging autoimmune disorder.

No description available.

No description available.

Monoclonal antibody-based immunotherapy has emerged as a promising treatment for B-cell lymphoma, with Rituximab (RTX) IgG1 targeting the CD20 surface protein showing significant clinical success in combination with chemotherapy (Bello & Sotomayor 2007). However, not all patients respond to RTX, whereby further studies are warranted to improve RTX efficacy. In this study, an in-house ELISA method was optimized to analyze cytokines from supernatants from human B cell lymphoma cell lines and monocytic cell cultures. Basal levels of the pro-inflammatory tumor necrosis factor α (TNF-α) and the immunosuppressive interleukin 10(IL-10) cytokines were investigated. The study shows several factors that can affect cytokine measurements in cell lines, such as time of culture, cell passage numbers, and incubation times of standards and samples in the ELISA. Furthermore, the correlation between IL-10 secretion of cell lines and phagocytosis was investigated using supernatant samples from phagocytosis assays of B-cell lymphoma cells treated with RTX and anti-CD47 mAbs. Notably, the pattern of IL-10 production from the samples varied depending on the treated antibodies and not by the intensity of the phagocytosis induced by the mAbs.In summary, this study shows that ELISA methods need to be tailored for analysis of cytokines in cell cultures, and highlights that cytokine levels not necessarily correspond to phagocytosis intensity induced by therapeutic mAbs.

O hidrogênio molecular (H2) exerce efeito antioxidante, anti-apoptótico e antiinflamatório. Nesse estudo testamos a hipótese que o H2 modula as mudanças cardiovasculares, inflamatórias e termorregulatórias na inflamação sistêmica (IS) induzida por lipopolissacarídeo (LPS) em diferentes doses (0,1 ou 1,5 mg/kg, intravenoso, induzindo IS moderada ou severa) em ratos machos Wistar (250-300 g). LPS ou salina foi injetada imediatamente antes do início dos 360 minutos de inalação do H2 (2% H2, 21% O2, balanceado com nitrogênio) ou ar ambiente (21% O2, balanceado com nitrogênio). A temperatura corporal (Tc) foi mensurada por datalogger pré-implantados na cavidade peritoneal. O H2 não causou mudança nos parâmetros cardiovasculares, inflamatórios e na Tc dos ratos controle (tratados com salina). Durante a IS moderada o H2 reduziu o surgimento das citocinas pró-inflamatórias no plasma (TNF-? e IL-6) enquanto causou um aumento da IL-10 plasmática (citocina anti-inflamatória) e preveniu a febre. Durante a IS severa o H2 potencializou a hipotermia e preveniu a febre e a hipotensão. Além disso, o H2 causou uma redução no surgimento das citocinas pró-inflamatórias (TNF-? e IL-1? do plasma) e prostaglandina E2 [(PGE2), no plasma e no hipotálamo], e um aumento da IL-10 plasmática. Esses dados são consistentes com o entendimento que o H2 atenua a febre na IS moderada e durante a IS severa potencializa a hipotermia, previne a hipotensão e exerce um efeito antiinflamatório forte o suficiente para prevenir a febre alterando a sinalização febrigênica e alterando a produção hipotalâmica de PGE2 / Molecular hydrogen (H2) exerts anti-oxidative, anti-apoptotic, and anti-inflammatory effects. Here we tested the hypothesis that H2 modulates cardiovascular, inflammatory, and thermoregulatory changes in systemic inflammation (SI) induced by lipopolysaccharide (LPS) at different doses (0.1 or 1.5 mg/kg, intravenously, to induce mild or severe SI) in male Wistar rats (250-300 g). LPS or saline was injected immediately before the beginning of 360- minute inhalation of H2 (2% H2, 21% O2, balanced with nitrogen) or room air (21% O2, balanced with nitrogen). Deep body temperature (Tb) was measured by dataloggers preimplanted in the peritoneal cavity. H2 caused no change in cardiovascular, inflammatory parameters, and Tb of control rats (treated with saline). During mild SI, H2 reduced plasma surges of proinflammatory cytokines (TNF-? and IL-6) while caused an increase in plasma IL-10 (anti-inflammatory cytokine) and prevented fever. During severe SI, H2 potentiated hypothermia, and prevented fever and hypotension. Moreover, H2 caused a reduction in surges of proinflammatory cytokines (plasma TNF-? and IL-1?) and prostaglandin E2 [(PGE2), in plasma and hypothalamus], and an increase in plasma IL-10. These data are consistent with the notion that H2 blunts fever in mild SI, and during severe SI potentiates hypothermia, prevents hypotension and exerts anti-inflammatory effects strong enough to prevent fever by altering febrigenic signaling and ultimately down-modulating hypothalamic PGE2 production